Serán Bioscience, LLC | Serán BioScience
We are dedicated to constantly pushing the boundaries of science and technology to identify optimum approaches to improve patient outcome. We are a responsible corporate citizen and promote a clean, sustainable and diverse world. We are expanding our commercial building plans and capabilities. Our mission is to unlock the potential of your therapeutic asset and support you throughout your drug development journey. Serán was founded in 2016 to provide state of the art solutions for our clients. Smithey is the President, CEO and Co-founder of Serán BioScience. Smithey co-founded Agere Pharmaceuticals, a specialty CDMO, which was acquired by Patheon in 2015. Ketner has nearly three decades of pharmaceutical drug product expertise and business development leadership.
This company is:
Verified
Formulation Development | Serán BioScience
Optimized formulations to optimize therapeutic performance
Verified
Services | Serán BioScience
Services: You’re here because you need a CMC partner who is committed to your success. We can help.
Verified
Regulatory & IND Support | Serán BioScience
We don’t just deliver your clinical supplies. We deliver the data, too.
View all products
Keywords
Industries
Where is Serán Bioscience located?
The company Serán Bioscience is located in Bend, Oregon, United States. It's worth noting that the company may has more corporate locations
How many employees does Serán Bioscience approximately have?
As of the latest available information Serán Bioscience has around 51-100 employees worldwide.
When was Serán Bioscience founded?
Serán Bioscience was founded in 2016
In which industries does Serán Bioscience mainly work?
The company Serán Bioscience has it's main focus in the industries of Biotechnology, Science and Engineering, Health Care, Manufacturing
What is the current company status of Serán Bioscience?
Based on the founding year and the amount of employees the company Serán Bioscience seems to be a Medium-Sized Company at the current state. Note that over time that status can change
Seragon Pharmaceuticals
United States
251-500 Employees
2013
Serengen GmbH
Germany
1-10 Employees
2019
Seroscience
United States
11-50 Employees
2006
Seres Therapeutics
United States
101-250 Employees
2010
Seraphina Therapeutics
United States
1-10 Employees
2017
Serin
Qatar
11-50 Employees
2017
BTG Specialty Pharmaceuticals
United States
51-100 Employees
MercachemSyncom
Netherlands
251-500 Employees
2017
Topics which have been searched by others and may be interesting for you:
